ACVR2B and colorectal carcinoma: In line with this notion, using ACVR2B/Fc, a soluble ACVR2B synthetic peptide inhibitor, our group and others have demonstrated preservation of skeletal muscle in experimental models of lung and CRC cachexia, as well as following chronic administration of several anticancer drugs.17, 22, 23, 24